| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/02/2005 | EP1501944A2 Amplification of dna to produce single-stranded product of defined sequence and length |
| 02/02/2005 | EP1501943A2 Method to enhance homologous recombination |
| 02/02/2005 | EP1501942A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/02/2005 | EP1501941A1 Antisense modulation of jagged 2 expression |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501935A2 Low-cost production of peptides |
| 02/02/2005 | EP1501933A2 Reversible masking of liposomal complexes for targeted delivery |
| 02/02/2005 | EP1501932A2 Method for producing multiple unsaturated fatty acids in plants |
| 02/02/2005 | EP1501931A2 Chimeric snrna molecules carrying antisense sequences against the splice junctions of the dystrophin gene and their therapeutic applications |
| 02/02/2005 | EP1501930A2 Oligomeric compounds for the modulation hif-1alpha expression |
| 02/02/2005 | EP1501929A2 Cgrp binding nucleic acids |
| 02/02/2005 | EP1501928A1 Assay for melanogenesis |
| 02/02/2005 | EP1501927A2 In vitro mutagenesis, phenotyping, and gene mapping |
| 02/02/2005 | EP1501923A2 Pak5-related compositions and methods |
| 02/02/2005 | EP1501870A2 Rsv proteins, antibodies, compositions, methods and uses |
| 02/02/2005 | EP1501868A1 Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same |
| 02/02/2005 | EP1501866A2 Apo-2 ligand variants and uses thereof |
| 02/02/2005 | EP1501863A2 Kinase anchor protein muteins, peptides thereof, and related methods |
| 02/02/2005 | EP1501861A1 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 02/02/2005 | EP1501860A2 Modulation of heat-shock-protein-based immunotherapies |
| 02/02/2005 | EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof |
| 02/02/2005 | EP1501856A2 Anti-her2 antibody variants |
| 02/02/2005 | EP1501855A2 Novel compositions and methods in cancer |
| 02/02/2005 | EP1501854A2 Antisense modulation of hmgi-c expression |
| 02/02/2005 | EP1501853A2 RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/02/2005 | EP1501852A2 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 02/02/2005 | EP1501851A1 Process for preparing oligonucleotides |
| 02/02/2005 | EP1501812A1 Pna monomer and precursor |
| 02/02/2005 | EP1501550A1 Non-viral gene delivery system |
| 02/02/2005 | EP1501544A2 Alcam and alcam modulators |
| 02/02/2005 | EP1501543A1 Use of modified novirhabdoviruses to obtain vaccines |
| 02/02/2005 | EP1501540A1 T-cell epitodes in carboxypeptidase g2 |
| 02/02/2005 | EP1501465A2 Vectors having both isoforms of beta-hexosaminidase |
| 02/02/2005 | EP1501359A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 02/02/2005 | EP1501351A2 Short fragment homologous replacement to provide bse resistant cattle |
| 02/02/2005 | EP1501350A2 Activation of equine oocytes |
| 02/02/2005 | EP1501345A1 Regulated ethylene sensitivity to control flower longevity in a plant |
| 02/02/2005 | EP1480597A4 Screening, diagnostic and therapeutic methods relating to riz |
| 02/02/2005 | EP1461620A4 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 02/02/2005 | EP1440161A4 7118, a human arginine n-methyltransferase family member and uses therefor |
| 02/02/2005 | EP1436382A4 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 02/02/2005 | EP1432810A4 Production of recombinant proteins in vivo and use for generating antibodies |
| 02/02/2005 | EP1432451A4 Production of fusion proteins and use for identifying binding molecules |
| 02/02/2005 | EP1430150A4 Diagnostic probe detection system |
| 02/02/2005 | EP1412491A4 Compositions and methods utilizing dna polymerases |
| 02/02/2005 | EP1409514A4 Chimeric histone acetyltransferase polypeptides |
| 02/02/2005 | EP1285269B1 Lipid uptake assays |
| 02/02/2005 | EP1281078A4 Methods for screening and identifying host pathogen defense genes |
| 02/02/2005 | EP1268824B1 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 02/02/2005 | EP1266025A4 Protein scaffolds for antibody mimics and other binding proteins |
| 02/02/2005 | EP1242601B1 Trichoderma reesei xylanase |
| 02/02/2005 | EP1221490B1 Recombinant adenoviral vectors and their utilization in the treatment of liver cirrhosis |
| 02/02/2005 | EP1198584B1 Transcription-based gene mapping |
| 02/02/2005 | EP1078074B1 Mutant lactobacillus bulgaricus strains free from beta-galactoside activity |
| 02/02/2005 | EP1073718A4 Nucleic acids that control seed and fruit development in plants |
| 02/02/2005 | EP1064394B1 Method for ballistic transformation of caenorhabditis elegans |
| 02/02/2005 | EP1049802B1 Fluorimetric detection system of a nucleic acid |
| 02/02/2005 | EP1032683B1 Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same |
| 02/02/2005 | EP0981610B1 Compositions for treatment of disorders involving programmed cell death |
| 02/02/2005 | EP0966534B1 Compositions and methods for elimination of unwanted cells |
| 02/02/2005 | EP0928342B1 The use of modular oligonucleotides as probes or primers in nucleic acid based assay |
| 02/02/2005 | EP0917563B1 Micro-organism which can desulphurise benzothiophenes |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0852585B1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/02/2005 | EP0851769B1 Gene therapy using ovine adenoviral vectors |
| 02/02/2005 | EP0832227B1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 02/02/2005 | EP0826031B1 Ataxia-telangiectasia gene and its genomic organization |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | EP0674650B1 Nucleic acid probes for lactobacillus detection |
| 02/02/2005 | EP0613495B1 Transgenic non-human animals lacking prion proteins |
| 02/02/2005 | EP0606437B1 Non-shedding live herpesvirus vaccine |
| 02/02/2005 | CN1575342A A method for the determination of multiple analytes |
| 02/02/2005 | CN1575340A Compositions and methods for treating neurodegenerative diseases |
| 02/02/2005 | CN1575339A Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 02/02/2005 | CN1575338A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575336A Systems and methods for delivering interferon to a subject |
| 02/02/2005 | CN1575335A Pig mast cell cultures and uses thereof |
| 02/02/2005 | CN1575303A Human CDR-grafted antibodies and antibody fragments thereof |
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1575301A Administration of nucleic acid sequence to female animal |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1573330A Method for manufacturing a microarray and verifying the same |
| 02/02/2005 | CN1572878A Method for producing L-amino acid |
| 02/02/2005 | CN1572877A System and apparatus for injecting substance into cell |
| 02/02/2005 | CN1572876A Glyt1 conditional knock-out mice |
| 02/02/2005 | CN1572875A Anti-SARS vaccine |
| 02/02/2005 | CN1572874A Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof |
| 02/02/2005 | CN1572872A Method for the recombinant production of polypeptides |
| 02/02/2005 | CN1572871A Method of maintaining or improving a nitrile hydratase activity |
| 02/02/2005 | CN1572868A Method for producing target substance |
| 02/02/2005 | CN1572801A Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 02/02/2005 | CN1572800A Specific antibody of tumor-associated antigen SM5-1 and use thereof |
| 02/02/2005 | CN1572799A Novel severe respiratory tract syndrome coronary virus protein and its antibody and uses |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572796A Method and apparatus for recovering nucleic acids |
| 02/02/2005 | CN1572721A Method for fabricating a nanoarray using the self-assembly of supramolecules and staining of metals |
| 02/02/2005 | CN1572323A Vaccine against SARS virogene and its construction and use |
| 02/02/2005 | CN1187453C Cell lines for propagation of mutated herpes viruses |